MiNA Therapeutics

MiNA Therapeutics

MiNA Therapeutics

Pioneering the development of a new class of medicines that use small RNA to activate genes
Founded
2008
Raised
$30.7M
Follow us
Alexa global traffic share
Latest funding
£23,000,000
Venture capital (Series A) - 2020
aMoon
Team Size
1–10
Employees
£23,000,000 Venture capital (Series A)
FinSMEs

MiNA Therapeutics Secures £23M Series A Financing